| Rogelio D Naranja, | |
|
3003 Highway 95 Ste 104, Bullhead City, AZ 86442-7802 | |
| (928) 763-0250 | |
| (928) 763-0271 |
| Full Name | Rogelio D Naranja |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 3003 Highway 95 Ste 104, Bullhead City, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306950407 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 13156 (Arizona) | Primary |
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | 13156 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rogelio D Naranja, 59 Coyote Hills St, Henderson, NV 89012-4460 Ph: () - | Rogelio D Naranja, 3003 Highway 95 Ste 104, Bullhead City, AZ 86442-7802 Ph: (928) 763-0250 |
News Archive
The U.S. Food and Drug Administration has cleared for marketing the Binax NOW Malaria Test, the first authorized U.S. rapid test for malaria, a mosquito-borne disease caused by a parasite. The test is intended for laboratory use.
Circumcision is performed for various reasons, including those that are based on religion, aesthetics, or health. New research indicates that the procedure may help prevent prostate cancer in some men.
The Independent Allocation Vaccine Group (IAVG) was established by the WHO in January 2021 and is composed of 12 members who serve in their personal, independent capacities to review and assess Vaccine Allocation Decision (VAD) proposals generated by the COVAX Facility Joint Allocation Taskforce (JAT) on the volumes of vaccines that should be allocated to each participant under COVAX within a given time frame.
Idera Pharmaceuticals, Inc. today announced data from preclinical studies of IMO-8400, demonstrating a novel mechanism of action that may be applicable to the treatment of systemic lupus erythematosus (SLE) and psoriasis. IMO-8400 is an inhibitor of specific Toll-like receptors (TLRs).
› Verified 4 days ago
Heather A Shelton, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3015 Hway 95, # 109, Bullhead City, AZ 86442 Phone: 928-763-5055 Fax: 928-763-5056 | |
Dr. Mohamed Ibrahim Ramadan, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1145 Marina Blvd, Bullhead City, AZ 86442 Phone: 928-758-5905 Fax: 928-757-3256 | |
Muhammad Abu-saleh Nayer, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3015 Highway 95, Suite 109, Bullhead City, AZ 86442 Phone: 928-763-5055 Fax: 928-763-5056 |